IP Library Granted Patent US 7,566,557
Granted Patent B2
US 7,566,557 · App. 10/583,404 · Granted Jul 28, 2009

Gene variants coding for proteins from the metabolic pathway of fine chemicals

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,566,557
App. No.
10/583,404
Granted
Jul 28, 2009
Kind
B2
Abstract

The present invention relates to mutated nucleic acids and proteins of the metabolic pathway of fine chemicals, to processes for preparing genetically modified producer organisms, to processes for preparing fine chemicals by culturing genetically modified organisms, and to genetically modified organisms themselves.

Claims (25)

1. An isolated nucleic acid molecule encoding a transketolase selected from the group consisting of:

a) an isolated nucleic acid molecule encoding the amino acid sequence set forth in SEQ ID NO: 70, wherein (i) the amino acid residue at position 75 of SEQ ID NO: 70 is any amino acid except asparagine, (ii) the amino acid residue at position 332 of SEQ ID NO: 70 is any amino acid except alanine, or (iii) the amino acid residue at position 556 of SEQ ID NO: 70 is any amino acid except valine, or a full complement thereof; and

b) an isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 69, wherein the nucleic acid molecule comprises one or more nucleic acid modifications at (i) nucleotide residues 223-225 of SEQ ID NO: 69 such that nucleotide residues 223-225 of SEQ ID NO: 69 encode any amino acid except asparagine, (ii) nucleotide residues 994-996 of SEQ ID NO: 69 such that nucleotide residues 994-996 of SEQ ID NO: 69 encode any amino acid except alanine, or (iii) nucleotide residues 1666-1668 of SEQ ID NO: 69 such that nucleotide residues 1666-1668 of SEQ ID NO: 69 encode any amino acid except valine, or a full complement thereof.

2. An isolated nucleic acid construct, comprising at least one nucleic acid molecule of claim 1 .

3. The nucleic acid construct of claim 2 , comprising at least one promoter and a terminator.

4. A method for preparing an isolated transformed host cell comprising introducing into the host cell at least one of

a) the nucleic acid molecule of claim 1 ; or

b) a promoter which is heterologous to an endogenous nucleic acid molecule and which enables the expression of said endogenous nucleic acid molecule, wherein said nucleic acid molecule is selected from the group consisting of:

i) an isolated nucleic acid molecule encoding the amino acid sequence set forth in SEQ ID NO: 70, wherein either (a) the amino acid residue at position 75 of SEQ ID NO: 70 is any amino acid except asparagine, (b) the amino acid residue at position 332 of SEQ ID NO: 70 is any amino acid except alanine, or (c) the amino acid residue at position 556 of SEQ ID NO: 70 is any amino acid except valine, or a full complement thereof; and

ii) an isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 69, wherein the nucleic acid molecule comprises one or more nucleic acid modifications at either (a) nucleotide residues 223-225 of SEQ ID NO: 69 such that nucleotide residues 223-225 of SEQ ID NO: 69 encode any amino acid except asparagine, (b) nucleotide residues 994-996 of SEQ ID NO: 69 such that nucleotide residues 994-996 of SEQ ID NO: 69 encode any amino acid except alanine, or (c) nucleotide residues 1666-1668 of SEQ ID NO: 69 such that nucleotide residues 1666-1668 of SEQ ID NO: 69 encode any amino acid except valine, or a full complement thereof.

5. The method of claim 4 , wherein the nucleic acid molecule of a), or the promoter of b), is introduced into a replicating plasmid or is integrated chromosomally.

6. The method of claim 4 , wherein the promoter of b) is functionally linked to the endogenous nucleic acid molecule.

7. An isolated transformed host cell, transformed with at least one of

a) the nucleic acid molecule of claim 1 ; or

c) a promoter which is heterologous to an endogenous nucleic acid molecule and which enables the expression of said endogenous nucleic acid molecule, wherein said nucleic acid molecule is selected from the group consisting of:

i) an isolated nucleic acid molecule encoding the amino acid sequence set forth in SEQ ID NO: 70, wherein either (a) the amino acid residue at position 75 of SEQ ID NO: 70 is any amino acid except asparagine, (b) the amino acid residue at position 332 of SEQ ID NO: 70 is any amino acid except alanine, or (c) the amino acid residue at position 556 of SEQ ID NO: 70 is any amino acid except valine, or a full complement thereof; and

ii) an isolated nucleic acid molecule comprising the nucleotide sequence set forth in SEQ ID NO: 69, wherein the nucleic acid molecule comprises one or more nucleic acid modifications at either (a) nucleotide residues 223-225 of SEQ ID NO: 69 such that nucleotide residues 223-225 of SEQ ID NO: 69 encode any amino acid except asparagine, (b) nucleotide residues 994-996 of SEQ ID NO: 69 such that nucleotide residues 994-996 of SEQ ID NO: 69 encode any amino acid except alanine, or (c) nucleotide residues 1666-1668 of SEQ ID NO: 69 such that nucleotide residues 1666-1668 of SEQ ID NO: 69 encode any amino acid except valine, or a full complement thereof.

8. The isolated transformed host cell of claim 7 , wherein the organism is capable of producing an amino acid.

9. A method for the preparation of an amino acid, comprising culturing the isolated transformed host cell of claim 7 in a culturing medium under conditions suitable for the preparation of an amino acid.

10. The method of claim 9 , wherein the amino acid is isolated from the isolated transformed host cell and/or the culturing medium.

11. The method of claim 9 , wherein the isolated transformed host cell is a microorganism.

12. The method of claim 11 , wherein the microorganism belongs to the bacterial genus Corynebacterium or Brevibacterium.

13. The method of claim 9 , wherein the amino acid is selected from the group consisting of L-lysine, L-threonine and L-methionine.

14. The isolated nucleic acid molecule of claim 1 (a), wherein the amino acid residue at position 75 of SEQ ID NO: 70 is aspartic acid, the amino acid residue at position 332 of SEQ ID NO: 70 is threonine, or the amino acid residue at position 556 of SEQ ID NO: 70 is isoleucine.

15. The isolated nucleic acid molecule of claim 1 (b) wherein nucleotide residues 223-225 of SEQ ID NO: 69 encode aspartic acid, nucleotide residues 994-996 of SEQ ID NO: 69 encode threonine, or nucleotide residues 1666-1668 of SEQ ID NO: 69 encode isoleucine.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2016
From: PAIK KWANG INDUSTRIAL CO., LTD.
To: DAESANG CORP.
Reel/Frame 038241/0026 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT COUNTRY LISTED FOR ASSIGNEE PREVIOUSLY RECORDED ON REEL 021383 FRAME 0240. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT ASSIGNEE COUNTRY FROM DEM REP OF KOREA TO REPUBLIC OF KOREA. Recorded Sep 19, 2008
From: BASF SE
To: PAIK KWANG INDUSTRIAL CO., LTD.
Reel/Frame 021558/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2008
From: BASF SE
To: PAIK KWANG INDUSTRIAL CO., LTD.
Reel/Frame 021383/0240 →
CHANGE OF NAME Recorded Jun 5, 2008
From: BASF AKTIENGESELLSCHAFT
To: BASF SE
Reel/Frame 021062/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2007
From: KLOPPROGGE, CORINNA; ZELDER, OSKAR; KROGER, BURKHARD; SCHRODER, HARTWIG; HAEFNER, STEFAN; RUFFER, UWE; GRAEF, CLAUDIA ISABELLA; HABERHAUER, GREGOR
To: BASF AKTIENGESELLSCHAFT
Reel/Frame 020212/0899 →